ATLASNautilus Biotechnology (NAUT) earnings date: expected January 23–29
Nautilus Biotechnology (NAUT) has not announced its next earnings date yet. Based on its last 4 reports, ATLAS expects it around January 23–29. That is an estimate, not a confirmed date.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on NAUT
| Last price | $2.34 (-14.5%) |
|---|---|
| Normal 1-day range (±1σ) | ±10.4% |
| Earnings beat history | Beat the EPS estimate in 6 of the last 6 reports |
These figures come from the same calibrated model and valuation as the Nautilus Biotechnology stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Expected around January 23–29 (estimate). One email the day before, with ATLAS’s read on Nautilus Biotechnology. You can switch it off at any time.
Alert me before NAUT reportsFree to start. Creating an account takes under a minute.
Notify me when Nautilus Biotechnology reports
Track NAUT free Add Nautilus Biotechnology to a free ATLAS watchlist and see its next report date in one place.
NAUT earnings at a glance
| Next report | Not announced · expected around January 23–29 (ATLAS estimate) |
|---|---|
| Last report | Oct 27, 2026 · Beat |
| Beat rate (last 6 reports) | 6 of 6 (100%) |
| Average EPS surprise | +19.7% |
| Average move around a report | ±16.1% (last 6) |
| Sector | Healthcare · Biotechnology |
The expected window is an ATLAS estimate: it takes the typical gap between Nautilus Biotechnology’s last 4 reports and adds it to the most recent one. Companies announce the real date a few weeks ahead, and ATLAS switches the page to the confirmed date as soon as it is published.
Nautilus Biotechnology earnings history: last 6 reports
Nautilus Biotechnology last reported on Oct 27, 2026: EPS of -$0.12 against an estimate of -$0.14 (+14.3% surprise), a beat.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Oct 27, 2026 | -$0.14 | -$0.12 | +14.3% | Beat | +31.6% |
| Jul 28, 2026 | -$0.14 | -$0.11 | +21.4% | Beat | -37.4% |
| Jun 8, 2026 | $0.48 | $0.50 | +4.2% | Beat | -1.7% |
| Apr 28, 2026 | -$0.14 | -$0.12 | +14.3% | Beat | -2.7% |
| Feb 26, 2026 | -$0.14 | -$0.11 | +21.4% | Beat | -16.3% |
| Jan 8, 2026 | $0.07 | $0.10 | +42.9% | Beat | -7.2% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for NAUT
See the fair value, the probability range and the earnings history of Nautilus Biotechnology on its ATLAS page.
Nautilus Biotechnology (NAUT) stock analysisPlans from €3.99 a month.
Nautilus Biotechnology earnings: frequently asked questions
When is Nautilus Biotechnology (NAUT) next earnings date?
Nautilus Biotechnology has not announced its next report. Its last 4 reports came Oct 27, 2026, Jul 28, 2026, Apr 28, 2026, Feb 26, 2026, so ATLAS estimates the next one around January 23–29. This is an estimate based on that pattern, not a confirmed date.
How often does NAUT beat earnings estimates?
Of its last 6 reports with a recorded result, Nautilus Biotechnology beat the EPS estimate 6 times; the average surprise was +19.7%. Past results do not predict the next one.
How much does NAUT move around earnings?
Over its last 6 reports the stock moved an average of 16.1% (absolute, from the close before the report day to the close after it), and finished higher 1 of 6 times.
Did Nautilus Biotechnology beat earnings estimates last quarter?
Nautilus Biotechnology last reported on Oct 27, 2026: EPS of -$0.12 against an estimate of -$0.14 (+14.3% surprise), a beat.
How much does NAUT usually move in a day?
On a normal trading day the ATLAS model puts NAUT’s one-day range at about ±10.4%, with a 47% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Educational information, not investment advice. Disclaimer